Expert reviews in molecular medicine
Targeting CD39 as a therapeutic for cancer immunotherapy.
Zhongliang Li, Weiguo Xu, Hang Fai Kwok
Published: 202610.1017/erm.2026.10033
No abstract available for this study.
Zhongliang Li, Weiguo Xu, Hang Fai Kwok
No abstract available for this study.